US Broker Ratings

Mind Medicine (MindMed) Inc. (MNMD): Analyst Ratings Signal a Potential 90% Upside for Biotech Investors

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a promising player within the biotechnology sector, is captivating investor attention with an impressive potential upside of 90.22%. This clinical-stage biopharmaceutical company, headquartered in..

Immunome, Inc. (IMNM) Investor Outlook: Analyzing the 67.95% Potential Upside in Biotech

Immunome, Inc. (IMNM), a clinical-stage biotechnology company based in Bothell, Washington, has recently captured the attention of investors with its promising portfolio of cancer therapies and a notable 67.95% potential..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating Challenges in the Healthcare Sector

InnovAge Holding Corp. (NASDAQ: INNV) presents an intriguing case for investors interested in the healthcare sector, particularly those focused on medical care facilities. Headquartered in Denver, Colorado, InnovAge focuses on..

Pharvaris N.V. (PHVS) Stock Analysis: A Promising 51% Upside in the Biotech Sector

Pharvaris N.V. (NASDAQ: PHVS), a Switzerland-based biotechnology firm, has captured the attention of investors with its focus on developing therapies for rare diseases, particularly those related to angioedema. As the..

Upstream Bio, Inc. (UPB) Investor Outlook: Unveiling a 156% Potential Upside in Biotechnology

Upstream Bio, Inc. (NASDAQ: UPB), a clinical-stage biotechnology company headquartered in Waltham, Massachusetts, is capturing investor attention with its promising pipeline focused on treating inflammatory diseases. Recently, the company has..

Avadel Pharmaceuticals plc (AVDL): Investor Outlook with a 47% Upside Potential

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a promising player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Dublin, Ireland, this biopharmaceutical company is..

Maravai LifeSciences Holdings (MRVI): Consensus and Growth Potential with a 21% Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a notable player in the biotechnology sector, is capturing attention with its 21.21% potential upside, according to analyst ratings. Headquartered in San Diego, California,..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Exploring a 179% Potential Upside in Biotech Innovation

Investors in the biotechnology sector have their eyes on Nurix Therapeutics, Inc. (NASDAQ: NRIX), a clinical-stage biopharmaceutical company making waves with its cutting-edge therapeutic developments. Operating from the heart of..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: A Promising Biotech Play with 72% Upside Potential

Bicara Therapeutics Inc. (NASDAQ: BCAX), a clinical-stage biopharmaceutical company based in Boston, Massachusetts, is capturing significant attention from investors with its innovative approach to cancer treatment. Specializing in the development..

SIGA Technologies Inc. (SIGA) Stock Analysis: A Compelling Growth Story with 271.90% Revenue Surge

For investors with an eye on the healthcare sector, SIGA Technologies Inc. (NASDAQ: SIGA) presents a fascinating opportunity. This commercial-stage pharmaceutical company, headquartered in New York, specializes in the health..

Personalis, Inc. (PSNL) Stock Analysis: Navigating the Tumultuous Waters of Diagnostics & Research

Personalis, Inc. (NASDAQ: PSNL), a notable player in the healthcare sector, specifically within the diagnostics and research industry, is currently trading at $8.61, nudging slightly downward by 0.01% in recent..

Avanos Medical, Inc. (AVNS) Stock Analysis: Challenges and Opportunities Amidst Potential Growth

Investors eyeing the healthcare sector may want to consider the nuanced profile of Avanos Medical, Inc. (NYSE: AVNS), a medical device company with a diverse range of product offerings aimed..

Weave Communications, Inc. (WEAV) Stock Analysis: 70% Upside Potential Amid Healthcare Innovations

Investors interested in the healthcare technology space may find Weave Communications, Inc. (NYSE: WEAV) an intriguing opportunity, particularly given its substantial 70.91% potential upside. This Lehi, Utah-based company, with a..

Community Health Systems, Inc. (CYH) Stock Analysis: Evaluating a 14.98% Potential Upside Amid Healthcare Sector Challenges

Community Health Systems, Inc. (NYSE: CYH) is a key player in the healthcare sector, specifically within the medical care facilities industry in the United States. Despite being a significant provider..

CeriBell, Inc. (CBLL) Stock Analysis: Robust Revenue Growth and 134% Potential Upside Captivate Investors

CeriBell, Inc. (NASDAQ: CBLL), operating in the healthcare sector’s medical device industry, has been gaining significant attention from investors, showcasing a compelling blend of innovative technology and promising financial indicators...

Keros Therapeutics, Inc. (KROS) Stock Analysis: Exploring a Potential 42.68% Upside with Promising Biopharma Innovations

Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, has recently caught the attention of investors with its promising pipeline of novel therapeutics aimed at treating disorders linked to dysfunctional..

Zevra Therapeutics (ZVRA) Investor Outlook: Analyzing 114% Potential Upside in Biotech

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is capturing the spotlight in the biotech sector with its robust pipeline focused on rare diseases. With a current market capitalization of $607.38 million, this..

Enhabit, Inc. (EHAB) Stock Analysis: Exploring a 17% Potential Upside in the Healthcare Sector

Enhabit, Inc. (EHAB), a key player in the healthcare sector based in Dallas, Texas, is garnering attention from investors looking for potential growth in the medical care facilities industry. As..

Auna SA (AUNA) Stock Analysis: Exploring a Potential 83.64% Upside for Healthcare Investors

Auna SA (AUNA), a notable player in the healthcare sector, is gaining attention from investors due to its potential for significant upside. With its headquarters in Luxembourg, Auna operates a..

Bioventus Inc. (BVS) Stock Analysis: Unlocking 122.56% Potential Upside in Healthcare Innovation

Bioventus Inc. (NASDAQ: BVS) is making waves in the healthcare sector with its innovative approach to medical devices, particularly in the realm of pain relief and musculoskeletal therapies. Headquartered in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds